Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock, Par Value $0.01 per share
-
Shares outstanding
-
162M
-
Number of holders
-
238
-
Total 13F shares, excl. options
-
103M
-
Shares change
-
+1.28M
-
Total reported value, excl. options
-
$894M
-
Value change
-
+$23M
-
Put/Call ratio
-
1.64
-
Number of buys
-
114
-
Number of sells
-
-116
-
Price
-
$8.67
Significant Holders of NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) as of Q3 2025
331 filings reported holding NVAX - NOVAVAX INC - Common Stock, Par Value $0.01 per share as of Q3 2025.
NOVAVAX INC - Common Stock, Par Value $0.01 per share (NVAX) has 238 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 103M shares
of 162M outstanding shares and own 63.61% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (15.2M shares), BlackRock, Inc. (12.8M shares), SHAH CAPITAL MANAGEMENT (11.8M shares), STATE STREET CORP (7.2M shares), Sanofi (6.88M shares), D. E. Shaw & Co., Inc. (4.27M shares), COATUE MANAGEMENT LLC (3.84M shares), GEODE CAPITAL MANAGEMENT, LLC (3.79M shares), UBS Group AG (3.52M shares), and BANK OF AMERICA CORP /DE/ (3.1M shares).
This table shows the top 238 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.